Tissue Regenix Group Plc (TRX) — Financial Flexibility Index
Tissue Regenix Group Plc (TRX) has a Financial Flexibility Index of -0.01x as of June 2025. Free cash flow of GBX-152.00K (operating CF GBX-202.00K minus capex GBX50.00K) represents 0% of total liabilities (GBX18.56 Million). Check how strategically is Tissue Regenix Group Plc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tissue Regenix Group Plc Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Tissue Regenix Group Plc across 19 annual periods. See Tissue Regenix Group Plc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tissue Regenix Group Plc (2008–2024)
Year-by-year free cash flow to debt coverage for Tissue Regenix Group Plc. For the full company profile including market capitalisation, see Tissue Regenix Group Plc (TRX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | GBX2.43 Million | GBX-1.64 Million | GBX16.29 Million | ▲ +9.0% |
| 2023 | 0.14x | GBX1.90 Million | GBX1.04 Million | GBX13.89 Million | ▲ +535.4% |
| 2022 | -0.03x | GBX-409.10K | GBX-1.29 Million | GBX13.00 Million | ▲ +79.9% |
| 2021 | -0.16x | GBX-1.49 Million | GBX-2.98 Million | GBX9.47 Million | ▲ +70.2% |
| 2020 | -0.53x | GBX-4.68 Million | GBX-6.05 Million | GBX8.88 Million | ▲ +51.4% |
| 2019 | -1.08x | GBX-6.40 Million | GBX-7.05 Million | GBX5.90 Million | ▲ +13.2% |
| 2018 | -1.25x | GBX-6.36 Million | GBX-6.77 Million | GBX5.09 Million | ▲ +18.5% |
| 2018 | -1.53x | GBX-9.56 Million | GBX-9.79 Million | GBX6.24 Million | ▼ -0.5% |
| 2017 | -1.53x | GBX-9.52 Million | GBX-9.74 Million | GBX6.24 Million | ▲ +67.4% |
| 2016 | -4.68x | GBX-9.66 Million | GBX-10.70 Million | GBX2.06 Million | ▼ -12.1% |
| 2016 | -4.17x | GBX-11.63 Million | GBX-12.65 Million | GBX2.79 Million | ▲ +42.9% |
| 2015 | -7.31x | GBX-8.00 Million | GBX-8.12 Million | GBX1.09 Million | ▼ -52.6% |
| 2014 | -4.79x | GBX-8.72 Million | GBX-9.31 Million | GBX1.82 Million | ▲ +16.9% |
| 2013 | -5.76x | GBX-6.24 Million | GBX-6.48 Million | GBX1.08 Million | ▼ -78.5% |
| 2012 | -3.23x | GBX-3.29 Million | GBX-3.34 Million | GBX1.02 Million | ▲ +40.6% |
| 2011 | -5.44x | GBX-2.18 Million | GBX-2.34 Million | GBX400.37K | ▲ +23.3% |
| 2010 | -7.09x | GBX-362.65K | GBX-362.65K | GBX51.12K | ▲ +15.8% |
| 2009 | -8.43x | GBX-510.22K | GBX-510.22K | GBX60.53K | ▼ -27.3% |
| 2008 | -6.62x | GBX-552.80K | GBX-556.78K | GBX83.52K | — |